You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent adult T-cell leukemia/lymphoma

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Transformed Chronic

Not yet recruiting
  • Recurrent Transformed Chronic Lymphocytic Leukemia
  • +7 more
  • Biospecimen Collection
  • +9 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 15, 2023

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B Acute Lymphoblastic Leukemia Trial

Not yet recruiting
  • Recurrent B Acute Lymphoblastic Leukemia
  • +5 more
  • Interferon Beta-1A
  • +10 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 6, 2023

B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Recurrent B Acute

Recruiting
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 16, 2022

Determining the Mechanisms of Loss of CAR T Cell Persistence

Not yet recruiting
  • Acute Lymphoblastic Leukemia With Failed Remission
  • +4 more
    • (no location specified)
    Mar 29, 2023

    Lymphoblastic Leukemia, Lymphoblastic Leukemia in Children, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (Anti-CD19

    Recruiting
    • Lymphoblastic Leukemia
    • +5 more
    • Anti-CD19 CAR T-cells
    • Singapore, Singapore
    • +1 more
    Dec 4, 2022

    Acute T-lymphoblastic Leukemia, Acute T-lymphoblastic Lymphoma Trial in Xuzhou (CAR-T Cell Infusion)

    Recruiting
    • Acute T-lymphoblastic Leukemia
    • Acute T-lymphoblastic Lymphoma
    • CAR-T Cell Infusion
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Feb 23, 2023

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Tampa (Fludarabine, Cyclophosphamide,

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +4 more
    • Tampa, Florida
      Moffitt Cancer Center
    Jan 12, 2023

    Recurrent Anaplastic Large Cell Lymphoma, Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Mature T- and NK-Cell

    Active, not recruiting
    • Recurrent Anaplastic Large Cell Lymphoma
    • +10 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 30, 2023

    Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia Refractory, B-cell Lymphoma Recurrent Trial in São Paulo

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +5 more
    • São Paulo, Brazil
      Hospital Israelita Albert Einstein
    Jan 20, 2023

    Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

    Recruiting
    • Non-hodgkin Lymphoma
    • +2 more
    • CC312
    • Tianjin, Tianjin, China
      InstituteHBDH
    Sep 12, 2023

    Burkitt Lymphoma, Lymphoblastic Lymphoma, Adult, Acute Lymphoblastic Leukemia, Adult Trial in Zhuhai (Thiotepa,

    Recruiting
    • Burkitt Lymphoma
    • +2 more
    • Thiotepa, cyclophosphamide, cladribine, and cytarabine conditioning regimen
    • Zhuhai, Guangdong, China
      The Fifth Affiliated Hospital of Sun Yat-sen University
    Sep 25, 2023

    Leukemia, Lymphoma Trial in United States (SCRI-CAR22v2)

    Recruiting
    • Leukemia
    • Lymphoma
    • SCRI-CAR22v2
    • Los Angeles, California
    • +4 more
    Jan 18, 2023

    Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

    Recruiting
    • Relapsed or Refractory CD19+ B-cell Lymphoma
    • +2 more
    • TBI-2001
    • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jul 26, 2023

    Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent DLBCL Trial in Seattle (biological,

    Recruiting
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +20 more
    • Chimeric Antigen Receptor T-Cell Therapy
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 11, 2022

    Acute Lymphoid Leukemia, B-Cell Leukemia, Leukemia, Lymphocytic, B Cell Trial run by the National Cancer Institute (NCI)

    Not yet recruiting
    • Acute Lymphoid Leukemia
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022

    Hairy Cell and Other Leukemias, and to Develop Recombinant

    Recruiting
    • Hairy Cell Leukemia (HCL)
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      T-cell Lymphoma, T-cell Leukemia Trial in Indianapolis (CD4CAR)

      Recruiting
      • T-cell Lymphoma
      • T-cell Leukemia
      • CD4CAR
      • Indianapolis, Indiana
        Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
      Dec 16, 2022

      Factors of CMV Reactivation in Patients Receiving of CAR-T Cells

      Not yet recruiting
      • Cytomegalovirus Infections
      • +2 more
        • (no location specified)
        Sep 22, 2023

        Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)

        Recruiting
        • Neoplasms
        • +2 more
        • RD13-02 cell infusion
        • Xuzhou, Jiangsu, China
          Affiliated hospital of Xuzhou medical college
        Jun 7, 2023

        Non-hodgkin Lymphoma,B Cell, Multiple Myeloma, Acute Lymphoblastic Leukemia, Adult Trial in Atlanta (Fludarabine,

        Not yet recruiting
        • Non-hodgkin Lymphoma,B Cell
        • +2 more
        • Atlanta, Georgia
          Caitlin Guzowski
        Jun 9, 2023

        Acute Myeloid Leukemia, Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Anti-CD33 CAR

        Not yet recruiting
        • Acute Myeloid Leukemia
        • +3 more
        • Anti-CD33 CAR T-cells
        • Lymphodepletion Therapy
        • Duarte, California
          City of Hope Medical Center
        Jan 3, 2023

        B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,

        Not yet recruiting
        • B Acute Lymphoblastic Leukemia
        • +2 more
        • Azacitidine Injection
        • +2 more
        • (no location specified)
        Oct 15, 2023

        Adult T-cell Leukemia/Lymphoma, Extranodal NK-/T-cell Lymphoma, Nasal Type, Enteropathy-Associated T-Cell Lymphoma Trial run by

        Not yet recruiting
        • Adult T-cell Leukemia/Lymphoma
        • +4 more
        • CC-486 (5-azacitidine)
        • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Aug 17, 2022

        Prolymphocytic Leukemia, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Columbus, Salt

        Active, not recruiting
        • Prolymphocytic Leukemia
        • +4 more
        • Columbus, Ohio
        • +1 more
        Apr 29, 2022

        Patients Previously Treated WithMustang Bio CAR-T Cell

        Enrolling by invitation
        • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
        • +10 more
        • Prior MB-102 CAR-T cell investigational product.
        • Prior MB-106 CAR-T cell investigational product.
        • Duarte, California
        • +4 more
        Dec 8, 2022